Immunic Inc. (IMUX) Prices 5M Share Common Offering at $18/Sh

Pre-Open Movers 08/04: (BLNK) (HLIT) (IPHI) Higher; (MNK) (IMUX) (AIHS) Lower (more...)

After-Hours Stock Movers:

Mallinckrodt (NYSE: MNK) 35.4% LOWER; said it continues to work to resolve outstanding issues related to opioids, Acthar Gel, and other risks, as well as address overall debt levels, and is considering with its external advisors all options to address legal and financial challenges. While no final determination has been made, it is possible that Mallinckrodt plc and most of its subsidiaries could file for Chapter 11 reorganization in the near term.

Iconix Brand Group (NASDAQ: ICON)... More

After-Hours Movers 08/03: (YRCW) (SEDG) (VRNS) Higher; (IMUX) (AIHS) (SPCE) Lower (more...)

After-Hours Stock Movers:

YRC Worldwide (NASDAQ: YRCW) 45% HIGHER; reported Q2 EPS of ($1.09), $0.29 better than the analyst estimate of ($1.38). Revenue for the quarter came in at $1.02 billion versus the consensus estimate of $1.01 billion.

SolarEdge Technologies (NASDAQ: SEDG) 12% HIGHER; reported Q2 EPS of $0.70, $0.01 better than the analyst estimate of $0.69. Revenue for the quarter came in at $331.9 million versus the consensus estimate of $319.42 million. SolarEdge Technologies sees Q3 2020 revenue of $325-350 million, versus the consensus of $330.8... More

Immunic Inc. (IMUX) Announces Proposed Public Offering of 5 Million Shares of Common Stock

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced that it intends to offer and sell 5 million shares of its common stock in an underwritten public... More

Immunic Inc. (IMUX) PT Raised to $61 at BMO Capital, Following Drug Trial Results

BMO Capital analyst George Farmer raised the price target on Immunic Inc. (NASDAQ: IMUX) to $61.00 (from $40.00) while maintaining a Market Perform rating.

Pre-Open Movers 08/03: (ADT) (VAR) (MPC) Higher; (ALRM) (CLX) Lower (more...)

Pre-Open Stock Movers

ADT (NYSE: ADT) 62.3% HIGHER; ADT and Google (NASDAQ: GOOGL) today announced they are entering into a long-term partnership to create the next generation of smart home security offerings. The partnership will combine... More

Immunic Inc. (IMUX) PT Raised to $60 at H.C. Wainwright

H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Immunic Inc. (NASDAQ: IMUX) to $60.00 (from $45.00) while maintaining a Buy rating.... More

UPDATE: Immunic Inc. (IMUX) Announces Positive Top-Line Data from Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting MS

(Updated - August 3, 2020 5:53 AM EDT)

Immunic, Inc. (NASDAQ: IMUX) today announced positive top-line data from its phase 2 EMPhASIS trial of lead asset, IMU-838, the company's selective oral DHODH inhibitor, in patients with relapsing-remitting multiple sclerosis (RRMS). The study achieved all primary and... More